Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Operating Expenses (2024 - 2025)

BioAge Labs (BIOA) has disclosed Operating Expenses for 2 consecutive years, with $31.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 24.21% to $31.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.8 million through Dec 2025, up 30.16% year-over-year, with the annual reading at $101.8 million for FY2025, 30.16% up from the prior year.
  • Operating Expenses hit $31.5 million in Q4 2025 for BioAge Labs, up from $25.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $31.5 million in Q4 2025 to a low of $12.8 million in Q1 2024.